filmov
tv
KRAS
0:01:11
What is a KRAS mutation?
0:13:59
KRAS mutation
0:01:48
Ask Ruby: What is KRAS?
0:00:51
Personalized treatment approaches for patients with KRAS-mutant pancreatic cancer
0:04:43
Understanding NSCLC Treatment When You Have a KRAS Mutation
0:02:01
Clarifying the mechanism of EGFR inhibition in KRAS G13D colorectal cancer
0:00:58
KRAS G12C inhibitors for GI cancer
0:04:46
We're Finally Beginning to Crack the KRAS Nut in Colorectal Cancer
0:02:25
Cancer cell biology: mutated KRAS & reciprocal signalling
0:01:01
VDRHSE Talks: KRAS Protein
0:04:30
Drugging the Elusive KRAS
0:01:37
Treatment strategies for KRAS-mutant NSCLC with co-mutations
0:02:31
How do doctors treat lung cancer with KRAS mutations?
0:02:26
Targeting KRAS mutations in lung cancer
0:01:42
Treating KRAS G12C Mutations
0:00:41
Improving outcomes in KRAS-mutant pancreatic cancer
0:00:39
KRAS una GTPasa y miembro de la familia de las proteínas RAS
0:04:09
A New Era in Targeting KRAS
0:01:27
Advances in the development of KRAS inhibitors
0:01:34
Terri - How has your KRAS mutation affected the treatment options available to you?
0:04:59
Case Study: Treating KRAS-Mutant Adenocarcinoma
0:02:09
ESMO highlights: KRAS G12C inhibitors
0:02:12
Advances in the management of KRAS-mutant NSCLC
0:00:35
Data on KRAS inhibitors in lung cancer at WCLC 2022
Вперёд